Sunday, December 11, 2011

, David Cameron, to argue that researchers SNS data management in life sciences, will be easier to develop and test new drugs

David Cameron is to present the plans to allow patient records and other data from the NHS to share with private companies in life sciences.

In a speech Monday, the prime minister argued that provide access to private sector research firms for NHS information, it will be easier for them to develop and test new drugs and treatments.

will argue that the regulation limiting the reduction of such industry cooperation could stimulate life sciences, which already employs 160,000 people in the UK, with an annual turnover of 50 billion.

Andy Burnham, the shadow health secretary, said he opposed the idea in principle but the government must "tread carefully" because of confidentiality issues.

A source said Downing Street. "Britain has the potential to become a force in the life sciences industry in the world

"We want to see closer collaboration between the NHS and companies in life sciences -. greater exchange not only data, but more clinical trials in hospitals These changes not only stimulate the industry, but also potentially provide access to NHS treatment principles of the new, innovative medicines. "

The government has already taken steps to official data available in a wide range of areas. Some of this has commercial value, such as details of the Ordnance Survey mapping.

Andrew Witty, CEO GlaxoSmithKline, the pharmaceutical company told the Sunday Telegraph has welcomed the initiative for data exchange.

"Any action taken by the government to improve the environment in this country for the life sciences through these activities is welcome."

But Joyce Robins, the concern of the patient, said he was opposed to private companies the opportunity to have access to confidential medical information.


Blog Archive